+/CD8+、自然殺傷(NK)細(xì)胞活性明顯改善(P<0.05),觀察組患者CD4+/CD8+、NK細(xì)胞活性略高于對(duì)照組,無統(tǒng)計(jì)學(xué)意義。對(duì)照組患者治療結(jié)束的生活質(zhì)量的改善率為52.77%,觀察組患者的生活質(zhì)量改善率為80.00%,治療后生活質(zhì)量明顯提升,且觀察組明顯優(yōu)于對(duì)照組,有統(tǒng)計(jì)學(xué)的意義(P<0.05)。結(jié)論 十全大補(bǔ)丸聯(lián)合化療用于彌漫大B細(xì)胞淋巴瘤,增強(qiáng)患者機(jī)體的免疫功能,可以減少化療過程對(duì)人體的帶來不良反應(yīng),改善患者的生活質(zhì)量,值得臨床推廣。;Objective To explore the Shiquandabu Pill combined with chemotherapy in the clinical effect of diffuse large B-cell lymphoma. Methods Retrospective analysis of our hospital in May 2013 to June 2016 in the treatment of diffuse large B cell lymphoma in 152 patients as the object of the study. Shiquan Dabu Pill combined with chemotherapy for the observation group of 80 patients, the choice of conventional chemotherapy for the control group of 72 patients. The quality of life, cardiac function, immune function and adverse reactions of chemotherapy were measured before and after the treatment, and the curative effect was analyzed. Results In the observation group, 24 cases (30.00%) were completely relieved, 30 cases (37.50%) were partial remission, the total effective rate was 67.50%, the control group was completely relieved in 22 cases (30.55%), partial remission in 28 cases (38.89%), the total effective rate (69.44%), the difference was not statistically significant. The incidence and severity of adverse events such as neurotoxicity, abnormal liver function, thrombocytopenia, anemia, leukopenia, and fatigue in the control group were significantly higher than those in the control group (P < 0.05). After treatment, the levels of LVEF were decreased in both groups (P < 0.05), but there was no significant difference between the two groups. There was no significant difference in BNP and cTnT between the two groups before and after treatment The After treatment, the activity of CD4+/CD8+ and NK cells in the observation group was significantly improved (P < 0.05). The activity of CD4+/CD8+ and NK cells in the observation group was slightly higher than that in the control group. The improvement rate of quality of life was 52.77% in the treatment group and 80.00% in the observation group. The quality of life was significantly improved after treatment, and the observation group was superior to the control group, which was statistically significant (P < 0.05). Conclusion Shiquan Dabu Pill combined with chemotherapy for diffuse large B-cell lymphoma, and enhance immune function in patients with the body, can reduce the course of chemotherapy adverse reactions to the human body to improve the quality of life of patients worthy of clinical promotion."/>